Karnofsky Performance Status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma

World Journal of Urology

Volumn 32, Issue 2, 2014, Pages 385-391

  Evers, Patrick D ^a   Logan, Joshua E ^a   Sills, Veronica ^a   Chin, Arnold I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bladder cancer; Karnofsky Performance Status; Radical cystectomy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; COHORT ANALYSIS; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84897030045     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1110-7     Document Type: Article

References (12)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Heney NM, Ahmed S, Flanagan MJ et al (1983) Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086.
3. Stein JP (2003) Indications for early cystectomy. Urology 62: 591-595.
4. Bianco FJ, Justa D, Grignon DJ et al (2004) Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 22: 290-294. doi: 10. 1016/S1078-1439(03)00144-3.
5. Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55: 164-174. doi: 10. 1016/j. eururo. 2008. 07. 031.
6. Mayr R, May M, Martini T, et al. (2012) Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol. doi: 10. 1016/j. eururo. 2012. 03. 057.
7. Bajorin DF, Dodd PM, Mazumdar M et al (1999) Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17: 3173-3181.
8. Miller DCD, Taub DAD, Dunn RLR et al (2003) The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169: 105-109. doi: 10. 1097/01. ju. 0000039705. 36504. 12.
9. Lee CT, Madii R, Daignault S, et al. (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175: 1262-7- discussion 1267. doi: 10. 1016/S0022-5347(05)00644-0.
10. Koppie TM, Serio AM, Vickers AJ et al (2008) Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112: 2384-2392. doi: 10. 1002/cncr. 23462.
11. Fairey A, Chetner M, Metcalfe J et al (2008) Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta urology institute radical cystectomy database. J Urol 180: 128-134. doi: 10. 1016/j. juro. 2008. 03. 057.
12. Weizer AZ, Joshi D, Daignault S et al (2007) Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J Urol 177: 1287-1293. doi: 10. 1016/j. juro. 2006. 11. 060.